Related references
Note: Only part of the references are listed.Screening and identification of biomarkers associated with the immune infiltration of intracerebral hemorrhage
Hao Guo et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial
Terry B. Gernsheimer et al.
BLOOD (2022)
Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease: A Dutch nationwide survey
Loes L. Cornelissen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review
Arwa Z. Al-Riyami et al.
TRANSFUSION (2021)
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study
Jingcheng Zhao et al.
VOX SANGUINIS (2021)
Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia
Sherrill J. Slichter et al.
TRANSFUSION (2021)
Persistent Systemic Inflammation Is Associated With Bleeding Risk in Atrial Fibrillation Patients
Yuma Hamanaka et al.
CIRCULATION JOURNAL (2020)
The epidemiology of platelet transfusions: an analysis of platelet use at 12 US hospitals
Jerome Gottschall et al.
TRANSFUSION (2020)
The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes
Kathleen P. L. Cheok et al.
TRANSFUSION (2020)
The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial
Lise J. Estcourt et al.
TRIALS (2019)
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study
Abi Vijenthira et al.
LEUKEMIA RESEARCH (2019)
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial
Ian Roberts et al.
LANCET (2019)
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
Michael Dickinson et al.
BLOOD (2018)
Guidelines for the use of platelet transfusions
Lise J. Estcourt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
Haleema Shakur et al.
LANCET (2017)
Platelet Transfusion: A Clinical Practice Guideline From the AABB
Richard M. Kaufman et al.
ANNALS OF INTERNAL MEDICINE (2015)
Inflammation in intracerebral hemorrhage: From mechanisms to clinical translation
Yu Zhou et al.
PROGRESS IN NEUROBIOLOGY (2014)
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati et al.
BLOOD (2013)
Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss
K. Ker et al.
BRITISH JOURNAL OF SURGERY (2013)
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers
Simon J. Stanworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Platelet transfusions in haematology patients: are we using them appropriately?
L. J. Estcourt et al.
VOX SANGUINIS (2012)
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy
Charles L. Campbell et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Cross-national comparative performance of three versions of the ICD-10 Charlson index
Vijaya Sundararajan et al.
MEDICAL CARE (2007)
Transfusion Medicine 2 - Platelet transfusions
David F. Stroncek et al.
LANCET (2007)
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
Hagop Kantarjian et al.
CANCER (2007)
Platelet function and its clinical significance in the myelodysplastic syndromes
A Zeidman et al.
HEMATOLOGY JOURNAL (2004)
Share Paper
